Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02885467 · ClinicalTrials.gov registry record · NA
Nerve Burial for Preventing Neuralgia After Total Knee Arthroplasty
A NA study, sponsored by Medstar Health Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT02885467: Clinical Trial NA study, sponsored by Medstar Health Research Institute.
NCT02885467 is a NA study that was terminated before completion, run by Medstar Health Research Institute. The registered enrollment target is 58 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02885467, a NA study, was terminated before completion, sponsored by Medstar Health Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
This is a randomized study investigating whether identification, ligation, and burial of superficial branches of the saphenous nerve crossing the surgical field during total knee arthroplasty reduces the rate of post-operative anterior knee pain and neuralgia compared to standard total knee arthroplasty.
Primary Outcome
Measured by DN4 validated scoring tool
Interventions
- PROCEDURE Total knee arthroplasty with Saphenous nerve burial
- PROCEDURE Standard total knee arthroplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2013-08 |
| Est. Completion | 2018-05 |
| Phase | NA |
Why NCT02885467 stopped before completion
NCT02885467 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Total knee arthroplasty with Saphenous nerve burial is the first listed.
NCT02885467 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02885467 about?
NCT02885467 is a clinical study titled "Nerve Burial for Preventing Neuralgia After Total Knee Arthroplasty". This is a randomized study investigating whether identification, ligation, and burial of superficial branches of the saphenous nerve crossing the surgical field during total knee arthroplasty reduces the rate of post-operative anterior knee pain and neuralgia compared to standard total knee arthropl...
What is the current status of trial NCT02885467?
This trial is currently terminated. It is a NA study. The enrollment target is 58 participants. The study started on 2013-08. Estimated completion is 2018-05.
What interventions are being tested in trial NCT02885467?
The interventions under investigation include: Total knee arthroplasty with Saphenous nerve burial (PROCEDURE), Standard total knee arthroplasty (PROCEDURE).
Who is sponsoring clinical trial NCT02885467?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02885467's enrollment target sits among peer trials
58 1256th of 2000 higher than 740 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia